| Literature DB >> 18843377 |
Xiaoyong Yuan1, Bradley M Mitchell, Kirk R Wilhelmus.
Abstract
PURPOSE: To compare the global gene expression patterns in uninfected and fungus-infected mouse corneas at the onset of Candida albicans keratitis.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18843377 PMCID: PMC2562425
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Oligonucleotide primers used for real-time RT–PCR.
| Interleukin 1 beta ( | Mm00434228_m1 | 90 |
| Interleukin 6 ( | Mm00446191_m1 | 124 |
| Chemokine (C-C) ligand 4 ( | Mm00443111_ml | 70 |
| Chemokine (C-C) ligand 7 ( | Mm00443113_ml | 122 |
| Chemokine receptor 3 ( | Mm01216172_m1 | 98 |
| Chemokine receptor 5 ( | Mm01216171_ml | 78 |
| Interleukin 23 alpha ( | Mm00518984_m1 | 61 |
| Transforming growth factor beta 2 ( | Mm01321739_m1 | 109 |
| Glyceraldehyde-3-phosphate dehydrogenase ( | Mm99999915_gl | 107 |
The assay ID is from Applied Biosystems.
Results of RNA quality control evaluation.
| Infected 1 | 2.5 | 64.5 | 56.9 | 2.6 | 2.7 |
| Infected 2 | 2.5 | 54.1 | 54 | 2 | 2.1 |
| Infected 3 | 2.4 | 55.8 | 52.4 | 1.8 | 1.9 |
| Control 1 | 2.4 | 60.6 | 52.9 | 2.8 | 2.6 |
| Control 2 | 2.4 | 54.9 | 53.7 | 3 | 2.6 |
| Control 3 | 4.6 | 53.7 | 47.2 | 3.1 | 2.8 |
Triplicate samples of five-cornea pools were used from Candida albicans-infected or mock-infected control animals. PCall % is the percent of probe sets that are called “present” by Affymetrix’s algorithm. The 3′ to 5′ ratio is the 3′-end to 5′-end probe intensity ratio. The number of “present” probes for housekeeping probe sets (β-actin and GAPDH) was 3, and the number of spike-in probe sets (BioB, BioC, BioD, and CreX) was 2.
Categories of all genes significantly upregulated more than 100 fold.
| Chemokines | Chemokine (C-X-C) ligand 7 | 834.4 | 0.01 | ||
| chemokine (C-C) ligand 3 | 374.3 | 0.04 | |||
| chemokine (C-X-C) ligand 3 | 291.7 | 0.04 | |||
| chemokine (C-C) ligand 4 | 145.2 | 0.011 | |||
| chemokine (C-X-C) ligand 5 | 132.4 | 0.05 | |||
| Metalloproteinases | matrix metallopeptidase 13 | 375.4 | 0.001 | ||
| a disintegrin and metallopeptidase domain 8 | 108 | 0.01 | |||
| matrix metallopeptidase 8 | 102.5 | 0.0003 | |||
| Interleukin cytokines | interleukin 6 | 245.4 | 0.009 | ||
| interleukin 1 beta | 136.8 | 0.03 | |||
| oncostatin M | 122.7 | 0.006 | |||
| Leukocyte chemotaxis | formyl peptide receptor 1 | 145.2 | 0.01 | ||
| formyl peptide receptor, related sequence 2 | 132.8 | 0.05 | |||
| selectin, lymphocyte | 114.3 | 0.01 | |||
| Leukocyte surface molecules | C-type lectin domain family 4, member d | 118.2 | 0.04 | ||
| Ig superfamily receptors | C-type lectin domain family 4, member e | 180 | 0.02 | ||
| triggering receptor expressed on myeloid cells 1 | 136.4 | 0.0063 | |||
| Cell proliferation molecules | colony stimulating factor 3 (granulocyte) | 114.3 | 0.001 | ||
| high mobility group AT-hook 2 | 106.8 | 0.002 | |||
| G0/G1 switch gene 2 | 104.7 | 0.01 | |||
| Neuro-hormone mediators or receptors | immunoresponsive gene 1 | 328.9 | 0.03 | ||
| natriuretic peptide precursor type B | 204.1 | 0.000002 | |||
| MAS-related GPR, member A2 | 202.6 | 0.008 | |||
| inhibin beta-A | 201.9 | 0.0003 | |||
| Histamine synthesis | histidine decarboxylase | 251.5 | 0.03 | ||
| Prostaglandin synthesis | prostaglandin-endoperoxide synthase 2 | 106.2 | 0.004 | ||
| Intracellular molecules | cytochrome P450, family 4, subfamily f, polypeptide 18 | 164.8 | 0.01 | ||
| SAM domain, SH3 domain and nuclear localization signals, 1 | 145.7 | 0.002 | |||
| pleckstrin | 142.6 | 0.003 | |||
| Protein transport | solute carrier family 15, member 3 | 114.2 | 0.02 |
Figure 1Distribution of differentially regulated corneal genes. The microarray results compare the number of corneal genes in mouse corneas from Candida albicans-infected to the number of corneal genes in mock-infected control mouse corneas. The results are categorized by expression-level differences in twofold increments. A minimum of significant (p≤0.05), twofold upregulation or significant (p≤0.05) twofold down-regulation was required to be charted.
Figure 2Differential upregulation and down-regulation of corneal genes. Microarray results compare gene expression levels in mouse corneas from Candida albicans-infected compared to corneas from mock-infected controls. The results were assigned to general categories based upon the known functions of the gene products. The number of genes expressing a twofold or greater significant difference (p≤0.05) is plotted for the listed categories. Red bars represent the number of genes significantly down-regulated, and black bars represent the number of genes significantly upregulated.
Upregulated pathways in Candida albicans keratitis compared with mock-infected controls.
| Leukocyte extravasation | 16 | 191 | 44 | 0.23 |
| NF-κβ | 15.5 | 141 | 38 | 0.27 |
| Interleukin 10 | 13.2 | 68 | 23 | 0.34 |
| Interleukin 6 | 12.5 | 90 | 27 | 0.3 |
| Acute-phase response | 11.3 | 171 | 36 | 0.21 |
| B cell receptor | 6.7 | 144 | 26 | 0.18 |
| Toll-like receptor | 6.6 | 50 | 14 | 0.28 |
| Integrin | 6.1 | 188 | 30 | 0.16 |
| Natural killer cell | 6 | 112 | 19 | 0.17 |
| Granulocyte-macrophage colony-stimulating factor | 5.8 | 63 | 15 | 0.24 |
| Transforming growth factor beta | 4.9 | 84 | 16 | 0.19 |
| Chemokine | 4.7 | 75 | 15 | 0.2 |
| Interleukin 2 | 4.5 | 52 | 12 | 0.23 |
| Insulin-like growth factor 1 | 3.8 | 94 | 15 | 0.16 |
| T cell receptor | 3.5 | 100 | 15 | 0.15 |
| Epidermal growth factor | 3 | 47 | 9 | 0.19 |
| Vascular endothelial growth factor | 3 | 93 | 13 | 0.14 |
| Interleukin 4 | 3 | 69 | 11 | 0.16 |
| JAK/STAT | 2.6 | 112 | 19 | 0.17 |
| Apoptosis | 2.5 | 62 | 8 | 0.13 |
Real-time RT-PCR confirmation of microarray.
| Interleukin 1 beta | 342.4±477.5 | 378.0±317.4 | 0.92 |
| Interleukin | 376.0±295.4 | 388.1±318.9 | 0.96 |
| Chemokine (C-C) ligand 4 ( | 228.7±175.5 | 200.9±172.2 | 0.85 |
| Chemokine (C-C) ligand 7 ( | 60.9±51.7 | 14.9±9.8 | 0.21 |
| Chemokine receptor 3 ( | -6.0±3.5 | 14.5±4.3 | 0.004 |
| Chemokine receptor 5 ( | 1.1±1.1 | 2.3±0.9 | 0.20 |
| Interleukin 23 alpha | 9.1±3.3 | 14.2±9.9 | 0.44 |
| Transforming growth factor beta 2 | 1.8±1.0 | -1.8±3.7 | 0.19 |
Mean fold change ± standard deviation, comparing infected to mock-inoculated control corneas.